샘플 요청 목록

 카트 문의
시장보고서
상품코드
1879890

세계의 자가면역질환 진단 시장

Autoimmune Disease Diagnosis
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 자가면역질환 진단 시장은 2030년까지 69억 달러에 달할 전망

2024년에 49억 달러로 추정되는 세계의 자가면역질환 진단 시장은 2024-2030년의 분석 기간에 CAGR 6.0%로 성장하며, 2030년까지 69억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 소모품·어세이 키트는 6.4%의 CAGR을 기록하며, 분석 기간 종료까지 41억 달러에 달할 것으로 예측됩니다. 기기 부문의 성장률은 분석 기간에 5.4%의 CAGR로 추정되고 있습니다.

미국 시장은 13억 달러로 추정되는 한편, 중국은 CAGR 9.8%로 성장할 것으로 예측됩니다.

미국에서 자가면역질환 진단 시장은 2024년에 13억 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 9.8%로 추이하며, 2030년까지 16억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 CAGR 2.0%, 6.4%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.2%의 CAGR로 성장할 것으로 예측됩니다.

세계의 자가면역질환 진단 시장 - 주요 동향과 촉진요인 요약

현대 의학에서 자가면역질환 진단이 중요한 이유

자가면역질환은 면역체계가 자신의 조직을 잘못 공격하는 것을 특징으로 하는 현대 의학의 복잡하고 증가하는 과제입니다. 류마티스 관절염, 루푸스, 다발성 경화증, 1형 당뇨병에 이르기까지 80여 가지 이상의 다양한 자가면역질환이 확인되고 있으며, 효과적인 치료와 관리를 위해서는 정확한 진단이 필수적입니다. 이들 질환은 증상이 비특이적이고 다른 질환과 중복되는 경우가 많아 진단이 늦어지는 경우가 많고, 그 복잡성이 문제가 되고 있습니다. 장기 및 조직의 돌이킬 수 없는 손상을 방지하고, 환자의 예후를 개선하며, 의료 비용을 절감하기 위해서는 조기에 정확한 진단이 필수적입니다. 진단 과정에는 일반적으로 임상 평가, 실험실 검사, 영상 검사의 조합이 포함됩니다. 보다 민감하고 특이적인 바이오마커의 개발을 포함한 진단 기술의 발전으로 임상의들은 자가면역질환을 더 일찍, 더 정확하게 파악할 수 있게 되었으며, 이는 보다 정확한 치료와 환자의 삶의 질 향상으로 이어지고 있습니다.

자가면역질환 진단을 혁신하는 기술 발전이란?

기술 발전은 자가면역질환 진단을 혁신하고 보다 정확하고 조기에 발견할 수 있도록 하는 데 있으며, 매우 중요한 역할을 하고 있습니다. 첨단 면역측정법 및 분자진단법의 개발로 자가면역질환과 관련된 특정 자가항체 및 기타 바이오마커를 검출하는 능력이 크게 향상되었습니다. 효소면역측정법(ELISA), 화학발광측정법, 다중측정법 등의 기술을 통해 여러 개의 자가항체를 동시에 검출할 수 있으며, 환자의 면역상태를 종합적으로 파악할 수 있게 되었습니다. 또한 차세대 염기서열 분석(NGS)과 유전체학은 자가면역질환의 유전적 소인을 규명하기 위해 점점 더 많이 활용되고 있으며, 맞춤형 의료 접근을 가능하게 하고 있습니다. MRI, 초음파 검사 등 영상 진단 기술도 발전하여 류마티스 관절염, 전신성 홍반성 루푸스 등의 질환 진단에 필수적인 영향을 받은 조직과 장기의 상세한 시각화를 실현하고 있습니다. 이러한 기술 혁신은 진단 정확도를 향상시킬 뿐만 아니라, 확진에 이르는 시간을 단축시켜 적시에 효과적인 치료를 시작하는 데 매우 중요한 역할을 하고 있습니다.

자가면역질환 진단 툴의 도입 동향은 시장 역학에 의해 어떻게 형성되고 있는가?

자가면역질환 진단 툴의 도입은 질병 유병률 증가, 헬스케어에 대한 인식 증가, 맞춤형 의료의 추진 등 시장 역학적 상호작용의 영향을 받고 있습니다. 전 세계에서 증가하는 자가면역질환의 발생률은 중요한 촉진요인이며, 이러한 질환을 정확하게 파악할 수 있는 진단 검사에 대한 수요가 증가하고 있습니다. 의료진과 환자들은 조기 진단의 중요성에 대한 인식이 높아지면서 첨단 진단 툴의 사용이 증가하고 있습니다. 또한 맞춤형 의료의 추세는 환자의 특정 질병 프로파일에 대한 자세한 정보를 제공하여 개인화된 치료 전략을 가능하게 하는 진단 기술의 개발 및 채택을 촉진하고 있습니다. 보험 상환 정책과 의료 자원의 가용성 또한 시장 형성에 중요한 역할을 하며, 첨단 진단 기술에 대한 접근은 종종 이러한 요인에 의존합니다. 또한 제약업계가 자가면역질환에 대한 표적치료제 개발에 집중하고 있는 것은 진단기업과의 시너지를 창출하고 있습니다. 왜냐하면, 이러한 치료법으로부터 가장 큰 혜택을 받을 수 있는 환자를 식별하기 위해서는 정밀한 진단이 필수적이기 때문입니다.

자가면역질환 진단 시장의 성장을 이끄는 요인은?

자가면역질환 진단 시장의 성장은 고급 진단 툴에 대한 수요 증가에 기여하는 여러 요인에 의해 촉진되고 있습니다. 주요 촉진요인 중 하나는 전 세계에서 자가면역질환의 유병률이 증가하고 있으며, 이로 인해 정확하고 빠른 진단에 대한 요구가 증가하고 있습니다. 보다 민감하고 특이성이 높은 바이오마커의 개발과 같은 기술적 진보도 조기 발견과 맞춤 치료 접근을 가능하게 함으로써 시장 성장을 가속하고 있습니다. 진단 과정에서 차세대 염기서열 분석과 유전체학이 확대되고 있는 것도 시장을 더욱 확대시키고 있으며, 이러한 기술을 통해 유전적 소인을 파악하고 환자 개개인에 맞는 치료법을 조정할 수 있게 되었습니다. 또한 의료진과 환자 모두 자가면역질환에 대한 인식이 높아짐에 따라 검사 빈도가 증가하고 조기 개입이 이루어지고 있으며, 이는 이러한 복잡한 질환을 관리하는 데 필수적인 요소입니다. 신흥 시장의 헬스케어 인프라 확충과 선진국의 유리한 상환 정책도 시장 성장에 중요한 역할을 하고 있습니다. 이러한 요인과 더불어 제약회사와 진단기기 제조업체 간의 지속적인 협력으로 자가면역질환 진단 시장은 향후 수년간 지속적으로 확대될 것으로 보입니다.

부문:

제품(소모품·어세이 키트, 기기), 검사 유형(루틴 검사, 염증 마커, 자기 항체·면역학적 검사, 기타 검사 유형), 최종사용자(병원, 임상 검사실, 기타 최종사용자)

조사 대상 기업의 예

  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Euroimmun AG
  • Grifols International SA
  • Hycor Biomedical, Inc.
  • INOVA Diagnostics, Inc.
  • Protagen AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보를 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 쿼리하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지역적 시장에 대한 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.12.08

Global Autoimmune Disease Diagnosis Market to Reach US$6.9 Billion by 2030

The global market for Autoimmune Disease Diagnosis estimated at US$4.9 Billion in the year 2024, is expected to reach US$6.9 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 9.8% CAGR

The Autoimmune Disease Diagnosis market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Autoimmune Disease Diagnosis Market - Key Trends and Drivers Summarized

Why Is Autoimmune Disease Diagnosis Crucial in Modern Medicine?

Autoimmune diseases represent a complex and growing challenge in modern medicine, characterized by the immune system mistakenly attacking the body’s own tissues. With over 80 different autoimmune conditions identified, ranging from rheumatoid arthritis and lupus to multiple sclerosis and type 1 diabetes, accurate diagnosis is crucial for effective treatment and management. The complexity of these diseases often leads to delays in diagnosis, as symptoms can be non-specific and overlap with other conditions. Early and precise diagnosis is vital to prevent irreversible damage to organs and tissues, improve patient outcomes, and reduce healthcare costs. The diagnostic process typically involves a combination of clinical evaluation, laboratory testing, and imaging studies. Advances in diagnostic technologies, including the development of more sensitive and specific biomarkers, are helping clinicians identify autoimmune diseases earlier and with greater accuracy, leading to better-targeted therapies and improved quality of life for patients.

What Technological Advancements Are Revolutionizing Autoimmune Disease Diagnosis?

Technological advancements are playing a pivotal role in revolutionizing the diagnosis of autoimmune diseases, leading to more accurate and earlier detection. The development of advanced immunoassays and molecular diagnostics has significantly improved the ability to detect specific autoantibodies and other biomarkers associated with autoimmune conditions. Techniques such as enzyme-linked immunosorbent assays (ELISA), chemiluminescence assays, and multiplex assays allow for the simultaneous detection of multiple autoantibodies, providing a comprehensive picture of a patient’s immune status. Additionally, next-generation sequencing (NGS) and genomics are being increasingly utilized to identify genetic predispositions to autoimmune diseases, enabling personalized medicine approaches. Imaging technologies such as MRI and ultrasound have also advanced, providing detailed visualization of affected tissues and organs, which is crucial for diagnosing diseases like rheumatoid arthritis and lupus. These technological innovations are not only improving diagnostic accuracy but are also reducing the time required to reach a definitive diagnosis, which is critical in initiating timely and effective treatment.

How Are Market Dynamics Shaping the Adoption of Autoimmune Disease Diagnostic Tools?

The adoption of autoimmune disease diagnostic tools is being influenced by a complex interplay of market dynamics, including rising disease prevalence, increasing healthcare awareness, and the push towards personalized medicine. The growing incidence of autoimmune diseases globally is a significant driver, leading to greater demand for diagnostic tests that can accurately identify these conditions. Healthcare providers and patients are becoming more aware of the importance of early diagnosis, which is contributing to the increased use of advanced diagnostic tools. Additionally, the trend towards personalized medicine is driving the development and adoption of diagnostics that can provide detailed information on a patient’s specific disease profile, allowing for tailored treatment strategies. Reimbursement policies and the availability of healthcare resources also play a crucial role in shaping the market, as access to advanced diagnostics is often contingent on these factors. Furthermore, the pharmaceutical industry’s focus on developing targeted therapies for autoimmune diseases is creating a synergistic relationship with diagnostic companies, as precise diagnostics are essential for identifying patients who will benefit most from these treatments.

What Is Driving the Growth in the Autoimmune Disease Diagnosis Market?

The growth in the autoimmune disease diagnosis market is driven by several factors, each contributing to the increasing demand for advanced diagnostic tools. One of the primary drivers is the rising prevalence of autoimmune diseases worldwide, which is leading to a greater need for accurate and early diagnosis. Technological advancements, such as the development of more sensitive and specific biomarkers, are also driving market growth by enabling earlier detection and more personalized treatment approaches. The increasing adoption of next-generation sequencing and genomics in the diagnostic process is further expanding the market, as these technologies allow for the identification of genetic predispositions and the tailoring of treatments to individual patients. Additionally, the growing awareness of autoimmune diseases among both healthcare providers and patients is leading to more frequent testing and earlier intervention, which is essential for managing these complex conditions. The expanding healthcare infrastructure in emerging markets, coupled with favorable reimbursement policies in developed regions, is also playing a crucial role in the market’s growth. These factors, along with the ongoing collaboration between pharmaceutical and diagnostic companies, are ensuring that the autoimmune disease diagnosis market will continue to expand in the coming years.

SCOPE OF STUDY:

The report analyzes the Autoimmune Disease Diagnosis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables & Assay Kits, Instruments); Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other Test Types); End-Use (Hospitals, Clinical Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Euroimmun AG
  • Grifols International SA
  • Hycor Biomedical, Inc.
  • INOVA Diagnostics, Inc.
  • Protagen AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Autoimmune Disease Diagnosis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Autoimmune Conditions Generates Sustained Demand for Diagnostic Solutions
    • Technological Advancements in Biomarker Detection Propel Market Expansion
    • Shift Toward Personalized Medicine Expands Addressable Market for Autoimmune Diagnostics
    • Integration of Next-Generation Sequencing in Autoimmune Diagnosis Strengthens Business Case for Advanced Testing
    • Development of Multiplex Assays Generates Demand for Comprehensive Diagnostic Solutions
    • Rising Demand for Non-Invasive Diagnostic Methods Throws the Spotlight on Innovative Testing Approaches
    • Expanding Use of Genomics and Proteomics in Autoimmune Diagnosis Propels Market Growth
    • Consumer Demand for Faster and More Accurate Diagnostics Drives Innovation in Autoimmune Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Autoimmune Disease Diagnosis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Autoimmune Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Autoimmune Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables & Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables & Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables & Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Routine Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Routine Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Routine Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Inflammatory Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Inflammatory Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Inflammatory Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Autoantibodies & Immunologic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Autoantibodies & Immunologic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Autoantibodies & Immunologic Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Autoimmune Disease Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Autoimmune Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Autoimmune Disease Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Autoimmune Disease Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Autoimmune Disease Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Autoimmune Disease Diagnosis by Product - Consumables & Assay Kits and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Autoimmune Disease Diagnosis by Product - Percentage Breakdown of Value Sales for Consumables & Assay Kits and Instruments for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Autoimmune Disease Diagnosis by Test Type - Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Autoimmune Disease Diagnosis by Test Type - Percentage Breakdown of Value Sales for Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Autoimmune Disease Diagnosis by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Autoimmune Disease Diagnosis by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제